![Christopher Reyes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Reyes is the founder.
Dr. Reyes was the founder of Eclipse Therapeutics, Inc. (2011) as Director & Chief Scientific Officer.
Dr. Reyes is also the founder of Bloom Science, Inc. Former job includes Scientist at Biogen, Inc. Education includes an undergraduate degree from the University of California, Berkeley and a graduate degree from The University of California, San Francisco.
| Unternehmen | Position | Beginn |
|---|---|---|
Bloom Science, Inc.
 Bloom Science, Inc. Internet Software/ServicesTechnology Services Operates as platform for biotechnology company | Gründer | - |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Eclipse Therapeutics, Inc.
 Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics that target cancer stem cells and other forms cancer treatment | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eclipse Therapeutics, Inc.
Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics that target cancer stem cells and other forms cancer treatment | Health Technology |
Bloom Science, Inc.
Bloom Science, Inc. Internet Software/ServicesTechnology Services Operates as platform for biotechnology company | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
